Depomed competitors

Zippia score 4.0

Depomed main competitors are Janssen, Warner Chilcott, and Sanofi US.

Competitor Summary. See how Depomed compares to its main competitors:

Sanofi US has the most employees (110,000).
Employees at Janssen earn more than most of the competitors, with an average yearly salary of $96,292.

Work at Depomed?

Share your experience

Depomed vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Depomed	1995	4.0	Newark, CA	2	$342.7M	494
Noven	1987	4.6	Miami, FL	2	$520.0M	586
Endo Pharmaceuticals Inc	1997	4.7	Malvern, PA	3	$2.6B	385
Warner Chilcott	1968	4.2	Rockaway, NJ	1	$105.1M	3,000
Alpharma	1975	4.4	Madison, NJ	1	$350.0M	2,000
Daiichi Sankyo	2005	4.8	Parsippany-Troy Hills, NJ	2	$9.0B	15,348
KV Pharmaceutical	1942	4.1	Chesterfield, MO	1	$91.0M	7,500
Takeda Pharmaceuticals U.S.A., Inc.	1998	4.7	Deerfield, IL	14	$12.1B	30,481
Forest Pharmaceuticals Inc	1954	4.2	Saint Louis, MO	1	$40.0M	50
Janssen	1953	4.9	Raritan, NJ	4	$601.4M	1,500
Axcan Pharma US Inc	1991	4.2	Birmingham, AL	1	$470.4M	525
Organon	-	4.5	-	-	$6.4B	158
Santarus	1996	4.5	San Diego, CA	1	$218.0M	290
Sanofi US	1973	4.3	Bridgewater, NJ	1	$980.0M	110,000
Xanodyne Pharmaceuticals	2000	4.3	Newport, KY	1	$18.8M	100
Brad Pharm	1985	4.3	Fairfield, NJ	1	$145.0M	300
Odyssey Pharmaceuticals Inc	2000	3.7	East Hanover, NJ	1	$6.2M	9
Sebela Pharmaceuticals	2013	3.9	Roswell, GA	1	$5.0M	222
Pharmacia	1901	4.3	Kalamazoo, MI	1	$130.0M	350
Pernix Therapeutics Holdings	1996	3.8	Morristown, NJ	1	$146.1M	171
Aqua Pharmaceuticals	2004	4.3	West Chester, PA	1	$8.6M	71

Rate Depomed's competitiveness in the market.

Depomed salaries vs competitors

Among Depomed competitors, employees at Janssen earn the most with an average yearly salary of $96,292.

Compare Depomed salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Depomed	$72,486	$34.85	-
Noven	$69,661	$33.49	-
Endo Pharmaceuticals Inc	$78,978	$37.97	-
Warner Chilcott	$92,301	$44.38	-
Alpharma	$61,984	$29.80	-
Daiichi Sankyo	$82,543	$39.68	-

Compare Depomed job title salaries vs competitors

Company	Highest salary	Hourly salary
Depomed	$61,135	$29.39
Pernix Therapeutics Holdings	$83,788	$40.28
Janssen	$78,593	$37.79
Warner Chilcott	$75,530	$36.31
Axcan Pharma US Inc	$66,219	$31.84
Forest Pharmaceuticals Inc	$62,542	$30.07
Sanofi US	$62,448	$30.02
Takeda Pharmaceuticals U.S.A., Inc.	$62,221	$29.91
Organon	$61,951	$29.78
Endo Pharmaceuticals Inc	$61,900	$29.76
Daiichi Sankyo	$61,768	$29.70
Pharmacia	$61,642	$29.64
KV Pharmaceutical	$61,553	$29.59
Noven	$61,532	$29.58
Alpharma	$61,338	$29.49
Aqua Pharmaceuticals	$61,331	$29.49
Santarus	$61,195	$29.42
Xanodyne Pharmaceuticals	$60,740	$29.20
Sebela Pharmaceuticals	$60,485	$29.08
Odyssey Pharmaceuticals Inc	$60,462	$29.07

Do you work at Depomed?

Is Depomed able to compete effectively with similar companies?

Depomed jobs

Depomed demographics vs competitors

Compare gender at Depomed vs competitors

Job title	Male	Female
Takeda Pharmaceuticals U.S.A., Inc.	49%	51%
Janssen	51%	49%
Daiichi Sankyo	51%	49%
Endo Pharmaceuticals Inc	52%	48%
Sanofi US	53%	47%
Depomed	-	-

Male

Female

100%

75%

50%

25%

Depomed

Sanofi US

Endo Pharmaceuticals Inc

Daiichi Sankyo

Janssen

Takeda Pharmaceuticals U.S.A., Inc.

25%

50%

75%

100%

Compare race at Depomed vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Daiichi Sankyo	60%	15%	11%	10%	4%	9.5
Endo Pharmaceuticals Inc	60%	13%	12%	11%	4%	9.8
Sanofi US	59%	14%	11%	12%	4%	9.9
Takeda Pharmaceuticals U.S.A., Inc.	61%	13%	11%	12%	4%	9.7
Janssen	57%	19%	9%	11%	3%	9.7

Depomed and similar companies CEOs

CEOBio

John A. Sedor

Pernix Therapeutics Holdings

An intuitive leader who engenders a deep level of trust and loyalty while providing a clear vision and business strategy, with a proven track record in the pharmaceutical, generic, biotechnology and consumer product industries. Recognized for entrepreneurial leadership approach to turnaround and rapid growth environments, leveraging strategic creativity, consumer and professional customer insight, merger and acquisition experience and operational expertise, all driving shareholder value. Open to contract C-level and Board of Director positions.

Kristin Peck

Alpharma

John Fraher

Axcan Pharma US Inc

John Fraher is a Chief Executive Officer at Aptalis Pharma Inc, Chief Executive Officer at Eurand NV, and Board Member at Ellodi Pharmaceuticals and is based in United States. He has worked as Pres:Aptalis Pharma Technologies at Aptalis Pharma Inc, Production Manager at Fort Dodge Animal Health, and President at Aptalis Pharma Inc. John works or has worked as President:America at Eurand Pharmaceuticals Hldg. He attended University College Dublin between 1984 and 1989.

Ken Keller

Daiichi Sankyo

Paul Campanelli

Endo Pharmaceuticals Inc

Gary D. Glick

Odyssey Pharmaceuticals Inc

Mark Morse

Paul Hudson

Roger Boissonneault

Daniel Glassman